Literature DB >> 23708175

Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry.

Rachel Lampert1, Yongfei Wang, Jeptha P Curtis.   

Abstract

BACKGROUND: New implantable cardioverter/defibrillator (ICD) models are regularly introduced, incorporating technological advantages. The purpose of this study was to determine factors associated with use of a newer, higher-tech/higher-cost device, as opposed to a previously released device, among patients undergoing ICD implantation.
METHODS: We analyzed the 78,494 cases receiving new ICD implants submitted by 978 hospitals to the NCDR ICD Registry between January 2005 and June 2007. Devices were categorized as "previously released" 3 months after a new model from the same manufacturer was released. A nonparsimonious model including all demographic, clinical, provider, and hospital characteristics was created using logistic regression to predict use of a previously released device.
RESULTS: Overall, 36% of implants involved previously released devices. However, no demographic (race, gender, payor status), clinical, or provider characteristics had a meaningful impact on use of previously released devices. The model C-statistic was 0.602, suggesting that measured characteristics had a limited ability to differentiate those receiving a previously released device. However, individual hospitals varied greatly in use of "previously released" devices, from 3% in the lowest decile to 91% in the top decile. Among physicians implanting at >1 hospital, there was minimal correlation between use of previously released devices between hospitals, suggesting hospital policies or culture, rather than physician preference, drives the large interhospital variation seen.
CONCLUSIONS: The use of "previously released" devices is influenced minimally by measured patient or provider characteristics. Rather, the main determinant of whether patients receive the newest, versus a previously released device, appears to be practice patterns at individual hospitals.
Copyright © 2013 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23708175     DOI: 10.1016/j.ahj.2012.12.003

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

Review 1.  Approval of high-risk medical devices in the US: implications for clinical cardiology.

Authors:  Benjamin N Rome; Daniel B Kramer; Aaron S Kesselheim
Journal:  Curr Cardiol Rep       Date:  2014       Impact factor: 2.931

2.  FDA approval of cardiac implantable electronic devices via original and supplement premarket approval pathways, 1979-2012.

Authors:  Benjamin N Rome; Daniel B Kramer; Aaron S Kesselheim
Journal:  JAMA       Date:  2014 Jan 22-29       Impact factor: 56.272

3.  The Extent Hospital Organizational Factors Influence Inpatient Care Delivery: A Case Study Looking at Knee and Hip Replacement Surgery.

Authors:  Julie Ann Sakowski; Paula H Song
Journal:  Health Serv Insights       Date:  2022-07-04

4.  Can machine learning complement traditional medical device surveillance? A case study of dual-chamber implantable cardioverter-defibrillators.

Authors:  Joseph S Ross; Jonathan Bates; Craig S Parzynski; Joseph G Akar; Jeptha P Curtis; Nihar R Desai; James V Freeman; Ginger M Gamble; Richard Kuntz; Shu-Xia Li; Danica Marinac-Dabic; Frederick A Masoudi; Sharon-Lise T Normand; Isuru Ranasinghe; Richard E Shaw; Harlan M Krumholz
Journal:  Med Devices (Auckl)       Date:  2017-08-16

Review 5.  Decompensated Heart Failure With Ventricular Arrhythmia: How Useful Is VT Ablation?

Authors:  Gerasimos Dimitropoulos; Georgios Leventogiannis; Joseph De Bono
Journal:  Curr Heart Fail Rep       Date:  2018-08

6.  Effect of battery longevity on costs and health outcomes associated with cardiac implantable electronic devices: a Markov model-based Monte Carlo simulation.

Authors:  Jordana K Schmier; Edmund C Lau; Jasmine D Patel; Juergen A Klenk; Arnold J Greenspon
Journal:  J Interv Card Electrophysiol       Date:  2017-11-06       Impact factor: 1.900

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.